Search

everythinglearnresearchcommunity

for

Search:↓

Mitochondrial therapy and platelet-rich plasma therapy both stimulated hair regrowth in aging mice, with mitochondrial therapy showing similar effectiveness to plasma therapy.

More research is needed to find the best long-term treatments for Alopecia Areata.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Loss of a specific protein in skin cells causes symptoms similar to psoriasis.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Keratin proteins are essential for keeping the cells in the human colon healthy and stable.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

Ixekizumab may be an effective first treatment for a rare skin condition causing hair loss.

Brodalumab effectively treated a man's severe hand and foot psoriasis.

DHT inhibition may increase spinal bone growth in ankylosing spondylitis.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

IL-1 family cytokines are crucial for skin defense and healing, but their imbalance can cause skin diseases.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Some skin conditions may increase the risk of heart disease, but are not yet included in cardiovascular prevention guidelines.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.

Photodynamic therapy may not work for erythroplasia of Queyrat and could lead to invasive squamous cell carcinoma.

Wnt5a may contribute to psoriasis by reducing skin cell growth, blocking skin cell maturation, and increasing inflammation.

AIRE-deficient rats developed severe autoimmune disease similar to APECED, useful for testing treatments.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

Scalp psoriasis can cause different types of hair loss, with some patients developing permanent hair loss, and treatment may be stopped due to skin reactions.